Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis

By Kolibianakis E.M.   Kalogeropoulou L.   Griesinger G.   Papanikolaou E.G.   Papadimas J.   Bontis J.   Tarlatzis B.C.  

Human Reproduction Update, Vol. 13, Iss. 5, 2007-06 ,pp. : 445-452

Oxford University Press

Access to resources Recommend Favorite

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

By Kolibianakis E.M.   Collins J.   Tarlatzis B.C.   Devroey P.   Diedrich K.   Griesinger G.  

Human Reproduction Update, Vol. 12, Iss. 6, 2006-11 ,pp. : 651-671

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data

By Beck-Fruchter R.   Weiss A.   Shalev E.  

Human Reproduction Update, Vol. 14, Iss. 6, 2008-09 ,pp. : 553-561

Oxford University Press

Access to resources Recommend Favorite

GnRH antagonist in single-dose applications

By Olivennes F.  

Human Reproduction Update, Vol. 6, Iss. 4, 2000-08 ,pp. : 313-317

Oxford University Press

Access to resources Recommend Favorite

The use of GnRH antagonists in ovarian stimulation

By Olivennes F.  

Human Reproduction Update, Vol. 8, Iss. 3, 2002-05 ,pp. : 279-299

Oxford University Press

Access to resources Recommend Favorite